On Thursday, Following Stocks were among the “Top 100 Gainers” of U.S. Stock Market: Arotech Corporation (NASDAQ:ARTX), Banro Corporation (NYSEMKT:BAA), Prana Biotechnology Limited (NASDAQ:PRAN)

Arotech Corporation (NASDAQ:ARTX), with shares inclined 8.63%, closed at $3.65.

Banro Corporation (NYSEMKT:BAA), with shares jumped 5.74%, settled at $0.20.

Prana Biotechnology Limited (NASDAQ:PRAN), with shares climbed 7.90%, and closed at $1.23.

Latest NEWS regarding these Stocks are depicted underneath:

Arotech Corporation (NASDAQ:ARTX)

At the start of the this week, Arotech Corporation (ARTX), declared financial results for its fourth quarter and full-year ended December 31, 2014.

Full-Year 2014 Financial and Business Highlights:

• Total proceeds of $103.5 million in 2014, an raise of 17% contrast to 2013
• Adjusted EBITDA of $10.0 million in 2014, up from $6.5 million in 2013
• Gross margin raised to 31.6% in 2014, contrast to 27.2% in 2013
• Net revenue of $3.5 million in 2014, up from $2.2 million in 2013
• New orders totaling $96.0 million in 2014
• Accomplished attainment of UEC Electronics on April 1, 2014, adding engineering design, product development, rapid prototyping and innovative manufacturing services for military, aerospace and industrial customers
• Strengthened recurring proceeds through receipt of multiple follow-on orders from U.S. Army for Virtual Clearance Training Suite (VCTS) Programs totaling $24.7 million
• Awarded non-dilutive funding supporting research of Iron Flow Grid Storage Program from the Israel Office of the Chief Scientist
• Backlog of orders as of December 31, 2014 totaled about $69.9 million.

Fourth Quarter 2014 Financial and Business Highlights:

• Total proceeds of $28.6 million, an raise of 36% contrast to Q4 2013
• Adjusted EBITDA of $1.0 million, contrast to $380,000 in Q4 2013
• Declared consolidation of Power Systems Division’s U.S. facilities into one location

“This was an important and transformative year for Arotech that produced solid financial results and a record level of proceeds, surpassing the $100 million mark for the first time in our history,” commented Steven Esses, Arotech’s President and CEO. “Just as important, this growth is coupled with expanded gross margins enabled by our disciplined administration of the business and leveraging our infrastructure, ample capacity and deep industry expertise to deliver on new orders. New orders totaled about $96.0 million for the year, driven by a number of key orders in our businesses.”

“As we practiced during the fourth quarter, the timing of new orders cannot always be precisely projected and orders may slip or be accelerated based on factors outside our control, which leads to quarter-to-quarter fluctuations; for this reason, we do not believe it is to the benefit of long-term growth to try to manage our business on a quarterly basis. In addition, the structure of contracts and the mix of products can also change, as we saw this year, when these factors resulted in higher gross margins, contributing in part to our higher than predictable Adjusted EBITDA. We expect a normalization of our margins in future periods,” noted Mr. Esses.

Arotech Corporation is a leading provider of quality defense and security products for the military, law enforcement and homeland security markets, counting multimedia interactive simulators/trainers and advanced battery solutions, innovative energy administration and power distribution technologies, and zinc-air and lithium batteries and chargers. Arotech operates two major business divisions: Training and Simulation, and Power Systems.

Banro Corporation (NYSEMKT:BAA)

Formerly on March 12, Banro Corporation (BAA), notified holders of Series A Preference Shares of Banro (“Banro Series A Shares”) and holders of Preferred Shares of Banro Group (Barbados) Limited (“Barbados Preferred Shares”) that, further to the Corporation’s press release of March 5, 2015, the board of directors of each of Banro and Banro Group (Barbados) Limited has authorized and declared, in respect of the September 30, 2014 dividend payment date, a dividend payable of US$0.57 per Banro Series A Share and Barbados Preferred Share.

The dividend is payable to holders of record of Banro Series A Shares and Barbados Preferred Shares on March 19, 2015 and will be paid on March 23, 2015.

Banro Corporation is a Canadian gold mining corporation focused on production from the Twangiza mine, which began commercial production September 1, 2012, and completion of its second gold mine at Namoya located about 200 kilometres south of the Twangiza gold mine.

Prana Biotechnology Limited (NASDAQ:PRAN)

Prana Biotechnology Limited (PRAN)’s stock has price to sale ratio of 215.25, however, price to book ratio is 1.89. With recent incline, the year-to-date (YTD) performance reflected a -25% decline below last year. During the past month the stock gained 13.36%, bringing three-month performance to -33.15% and six-month performance to -44.84%. The mean recommendation of analysts for this stock is 3. (where 1=Buy, 5=Sale).

Prana Biotechnology Limited develops therapies for the treatment of neurodegenerative diseases in Australia. The corporation focuses on the Alzheimer’s and Huntington’s diseases, in addition to other age-related degeneration disorders.

DISCLAIMER:

This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.

All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.

Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.

Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.